BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ilan Y. Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track. J Leukoc Biol 2019;105:463-72. [PMID: 30476347 DOI: 10.1002/JLB.5RU0718-276RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ishay Y, Potruch A, Schwartz A, Berg M, Jamil K, Agus S, Ilan Y. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomed Pharmacother 2021;143:112228. [PMID: 34649354 DOI: 10.1016/j.biopha.2021.112228] [Reference Citation Analysis]
2 Ishay Y, Potruch A, Weksler-Zangen S, Shabat Y, Ilan Y. Augmented antiviral T cell immunity by oral administration of IMM-124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID-19. Drug Dev Res 2021. [PMID: 34596893 DOI: 10.1002/ddr.21890] [Reference Citation Analysis]
3 Ishay Y, Rotnemer-Golinkin D, Ilan Y. The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways. Int J Immunopathol Pharmacol 2021;35:20587384211053274. [PMID: 34789044 DOI: 10.1177/20587384211053274] [Reference Citation Analysis]
4 Forkosh E, Kenig A, Ilan Y. Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy. Pharmacol Res Perspect 2020;8:e00616. [PMID: 32608157 DOI: 10.1002/prp2.616] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
5 Zhang Y, Zhao M, Jiang X, Qiao Q, Liu T, Zhao C, Wang M. Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis. Front Pharmacol 2021;12:713197. [PMID: 34385924 DOI: 10.3389/fphar.2021.713197] [Reference Citation Analysis]